Effectiveness of Immersive Virtual Reality in People with Cancer Undergoing Antiblastic Therapy: A Randomized Controlled Trial |
| |
| Affiliation: | 1. Department of Biomedicine and Prevention, PhD School in Nursing Sciences and Public Health, University of Rome “Tor Vergata”, Rome, Italy;2. Oncology Unit, John Paul II Hospital of Olbia, Olbia, Italy;3. Psychology Department, University of Milano-Bicocca, Milan, Italy;4. Department of Medicine and Surgery, Research Unit Nursing Science, Campus Bio-Medico of Rome University, Rome, Italy;5. Fondazione Policlinico Universitario, Campus Bio-Medico, Rome, Italy;1. Department of Adult Health and Nursing Systems, School of Nursing, Virginia Commonwealth University, Richmond, Virginia;2. School of Medicine, Virginia Commonwealth University, Richmond, Virginia;3. School of Engineering, Virginia Commonwealth University, Richmond, Virginia;1. Clinical Research Nurse and Scientist, Hartford HealthCare Cancer Institute, Hartford, Connecticut, USA;2. Program Director of Inpatient Geriatric Services, Hartford Hospital, Hartford, Connecticut, USA;1. Assistant Professor, School of Nursing, College of Medicine, National Taiwan University and Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan;2. Assistant Professor, School of Nursing and Graduate Institute of Nursing, China Medical University and Nursing Department, China Medical University Hospital, Taichung City, Beitun District, Taiwan;3. Professor, Department of Obstetrics and Gynecology, Graduate Institute of Oncology & College of Medicine, National Taiwan University, Taipei, Taiwan;4. Assistant Professor, Department of Obstetrics and Gynecology, Graduate Institute of Oncology & College of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan;5. Professor, School of Nursing, College of Medicine, National Taiwan University and Department of Nursing, National Taiwan University Cancer Center Taipei, Taiwan. |
| |
| Abstract: | ObjectivesThis study aims to assess the effects of immersive Virtual Reality in people with cancer undergoing antiblastic therapy, on anxiety, fatigue and pain.Data SourcesThis is a randomized controlled three-arm trial. Seventy-four cancer patients were recruited from a regional hospital in Italy, and randomly allocated into three groups: a Virtual Reality group (n=25), a narrative medicine group (n=25) and a standard care group (n=24). The primary outcome was anxiety. Secondary outcomes included fatigue and pain. The outcomes were evaluated immediately before and after the interventions. The findings showed that anxiety decreased more in the Virtual Reality group (Δpre-post = 6.24, 95% CI 2.578 to 9.902, p=.001, d = 0.63) than in the narrative medicine group, whereas it did not change for those in the standard care group. Fatigue decreased in the Virtual Reality group (Δpre-post = 0.576, 95% CI 0.246 to 0.907, p=.001, d = 0.23), while remaining stable in the narrative medicine group, and increasing in the standard care group. Average levels of pain did not change before and after the intervention [F(1,71) = 1.06, p=.307, ηp2 = .015].ConclusionFindings show that virtual reality is effective to reduce anxiety and fatigue in people with cancer undergoing antiblastic therapy.Implications for Nursing PracticeVirtual Reality can be recommended as an complementary intervention to manage anxiety and fatigue in people with cancer during antiblastic therapy.Trial registrationClinicalTrials.gov NCT05629507. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
